PACS Group (NYSE:PACS) CEO Sells 110,035 Shares of Company Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 110,035 shares of PACS Group stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45. Following the completion of the transaction, the chief executive officer owned 54,324,982 shares in the company, valued at approximately $2,567,941,899.14. This trade represents a 0.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total transaction of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total transaction of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total transaction of $1,107,470.52.
• On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The shares were sold at an average price of $41.13, for a total transaction of $1,358,606.16.
• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total transaction of $476,226.67.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total transaction of $396,098.36.

PACS Group Stock Performance

NYSE PACS traded down $0.82 during trading hours on Friday, hitting $46.93. 958,006 shares of the stock were exchanged, compared to its average volume of 895,386. The company has a market cap of $7.43 billion, a price-to-earnings ratio of 27.28, a price-to-earnings-growth ratio of 1.40 and a beta of -0.08. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $49.49. The stock has a 50-day moving average of $43.61 and a 200 day moving average of $40.37. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. As a group, equities research analysts forecast that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on PACS shares. UBS Group increased their target price on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Royal Bank Of Canada lifted their price target on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Oppenheimer increased their price objective on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, JPMorgan Chase & Co. increased their price objective on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $58.80.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Ellsworth Advisors LLC acquired a new stake in shares of PACS Group in the 3rd quarter worth approximately $914,000. State of Alaska Department of Revenue raised its holdings in PACS Group by 29.0% during the third quarter. State of Alaska Department of Revenue now owns 6,715 shares of the company’s stock worth $279,000 after purchasing an additional 1,511 shares during the last quarter. GK Wealth Management LLC acquired a new position in PACS Group during the third quarter worth $41,000. Toth Financial Advisory Corp raised its holdings in PACS Group by 87.5% during the third quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock worth $62,000 after purchasing an additional 700 shares during the last quarter. Finally, Tidal Investments LLC acquired a new position in PACS Group during the second quarter worth $252,000.

PACS Group Company Profile

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.